712 related articles for article (PubMed ID: 4134836)
1. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
Abuid J; Larsen PR
J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
3. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A
Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092
[TBL] [Abstract][Full Text] [Related]
7. Effects of amiodarone on serum T3 and T4 concentrations in hyperthyroid patients treated with propylthiouracil.
Van Reeth O; Unger J
Thyroid; 1991; 1(4):301-6. PubMed ID: 1841729
[TBL] [Abstract][Full Text] [Related]
8. Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases.
Laurberg P; Vestergaard H; Nielsen S; Christensen SE; Seefeldt T; Helleberg K; Pedersen KM
J Clin Endocrinol Metab; 2007 Jun; 92(6):2149-56. PubMed ID: 17389703
[TBL] [Abstract][Full Text] [Related]
9. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.
Saberi M; Sterling FH; Utiger RD
J Clin Invest; 1975 Feb; 55(2):218-23. PubMed ID: 1173242
[TBL] [Abstract][Full Text] [Related]
10. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism.
Okamura K; Ikenoue H; Shiroozu A; Sato K; Yoshinari M; Fujishima M
J Clin Endocrinol Metab; 1987 Oct; 65(4):719-23. PubMed ID: 3654917
[TBL] [Abstract][Full Text] [Related]
11. The efficiency and safety of methimazole and propylthiouracil in hyperthyroidism: A meta-analysis of randomized controlled trials.
Tan S; Chen L; Jin L; Fu X
Medicine (Baltimore); 2021 Jul; 100(30):e26707. PubMed ID: 34397700
[TBL] [Abstract][Full Text] [Related]
12. Studies on the T3 suppression test by the 24-hour thyroidal 131I uptake in patients with Graves' disease: comparison of the effects of propylthiouracil and methylmercaptoimidazole.
Kobayashi I; Maruta S; Mori M; Ishii H; Ishihara H; Iriuchijima T; Takahashi M; Shimomura Y; Fukuda H
Endocrinol Jpn; 1983 Aug; 30(4):491-7. PubMed ID: 6200318
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
Azizi F; Khoshniat M; Bahrainian M; Hedayati M
J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
[TBL] [Abstract][Full Text] [Related]
14. Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat.
Männistö PT; Ranta T; Leppäluoto J
Acta Endocrinol (Copenh); 1979 Jun; 91(2):271-81. PubMed ID: 111448
[TBL] [Abstract][Full Text] [Related]
15. Effects of propylthiouracil and relatively small doses of iodide on early phase treatment of hyperthyroidism.
Kasai K; Suzuki H; Shimoda SI
Acta Endocrinol (Copenh); 1980 Mar; 93(3):315-21. PubMed ID: 7376794
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma 3,5,3'-triiodothyronine sulfate in rats with inhibited type I iodothyronine deiodinase activity, as measured by radioimmunoassay.
Rooda SJ; Kaptein E; Rutgers M; Visser TJ
Endocrinology; 1989 Feb; 124(2):740-5. PubMed ID: 2912698
[TBL] [Abstract][Full Text] [Related]
18. Opposite variations in serum T3 and reverse T3 during propylthiouracil treatment of thyrotoxicosis.
Laurberg P; Weeke J
Acta Endocrinol (Copenh); 1978 Jan; 87(1):88-94. PubMed ID: 579537
[TBL] [Abstract][Full Text] [Related]
19. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
[TBL] [Abstract][Full Text] [Related]
20. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
